BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33308260)

  • 1. Characteristics and genetic testing outcomes of patients with clinically suspected paraganglioma/pheochromocytoma (PGL/PCC) syndrome in Singapore.
    Ting KR; Ong PY; Wei SOG; Parameswaran R; Khoo CM; Deepak DS; Lee SC
    Hered Cancer Clin Pract; 2020 Dec; 18(1):24. PubMed ID: 33308260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline mutations and genotype-phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma.
    Pandit R; Khadilkar K; Sarathi V; Kasaliwal R; Goroshi M; Khare S; Nair S; Raghavan V; Dalvi A; Hira P; Fernandes G; Sathe P; Rojekar A; Malhotra G; Bakshi G; Prakash G; Bhansali A; Walia R; Kamalanathan S; Sahoo J; Desai A; Bhagwat N; Mappa P; Rajput R; Chandrashekhar SR; Shivane V; Menon P; Lila A; Bandgar T; Shah N
    Eur J Endocrinol; 2016 Oct; 175(4):311-23. PubMed ID: 27539324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational profile and genotype/phenotype correlation of non-familial pheochromocytoma and paraganglioma.
    Albattal S; Alswailem M; Moria Y; Al-Hindi H; Dasouki M; Abouelhoda M; Alkhail HA; Alsuhaibani E; Alzahrani AS
    Oncotarget; 2019 Oct; 10(57):5919-5931. PubMed ID: 31666924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation analysis of the SDHB and SDHD genes in pheochromocytomas and paragangliomas: identification of a novel nonsense mutation (Q168X) in the SDHB gene.
    Oishi Y; Nagai S; Yoshida M; Fujisawa S; Sazawa A; Shinohara N; Nonomura K; Matsuno K; Shimizu C
    Endocr J; 2010; 57(8):745-50. PubMed ID: 20505258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype-phenotype correlation in paediatric pheochromocytoma and paraganglioma: a single centre experience from India.
    Khadilkar K; Sarathi V; Kasaliwal R; Pandit R; Goroshi M; Shivane V; Lila A; Bandgar T; Shah NS
    J Pediatr Endocrinol Metab; 2017 May; 30(5):575-581. PubMed ID: 28432847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative genetic characterization and phenotype correlations in pheochromocytoma and paraganglioma tumours.
    Crona J; Nordling M; Maharjan R; Granberg D; Stålberg P; Hellman P; Björklund P
    PLoS One; 2014; 9(1):e86756. PubMed ID: 24466223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing new susceptibility genes in the cohort of apparently sporadic phaeochromocytoma/paraganglioma patients with clinical characteristics of hereditary syndromes.
    Pęczkowska M; Kowalska A; Sygut J; Waligórski D; Malinoc A; Janaszek-Sitkowska H; Prejbisz A; Januszewicz A; Neumann HP
    Clin Endocrinol (Oxf); 2013 Dec; 79(6):817-23. PubMed ID: 23551045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large germline deletions of mitochondrial complex II subunits SDHB and SDHD in hereditary paraganglioma.
    McWhinney SR; Pilarski RT; Forrester SR; Schneider MC; Sarquis MM; Dias EP; Eng C
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5694-9. PubMed ID: 15531530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis.
    Luchetti A; Walsh D; Rodger F; Clark G; Martin T; Irving R; Sanna M; Yao M; Robledo M; Neumann HP; Woodward ER; Latif F; Abbs S; Martin H; Maher ER
    Int J Endocrinol; 2015; 2015():138573. PubMed ID: 25883647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pheochromocytoma and paraganglioma: implications of germline mutation investigation for treatment, screening, and surveillance.
    Gómez AM; Soares DC; Costa AAB; Pereira DP; Achatz MI; Formiga MN
    Arch Endocrinol Metab; 2019 Jul; 63(4):369-375. PubMed ID: 31365623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline SDHB and SDHD mutations in pheochromocytoma and paraganglioma patients.
    Huang Y; Wang LA; Xie Q; Pang J; Wang L; Yi Y; Zhang J; Zhang Y; Chen R; Lan W; Zhang D; Jiang J
    Endocr Connect; 2018 Dec; 7(12):1217-1225. PubMed ID: 30352407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A decade (2001-2010) of genetic testing for pheochromocytoma and paraganglioma.
    Buffet A; Venisse A; Nau V; Roncellin I; Boccio V; Le Pottier N; Boussion M; Travers C; Simian C; Burnichon N; Abermil N; Favier J; Jeunemaitre X; Gimenez-Roqueplo AP
    Horm Metab Res; 2012 May; 44(5):359-66. PubMed ID: 22517557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary paragangliomas.
    Raygada M; Pasini B; Stratakis CA
    Adv Otorhinolaryngol; 2011; 70():99-106. PubMed ID: 21358191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TMEM127 screening in a large cohort of patients with pheochromocytoma and/or paraganglioma.
    Abermil N; Guillaud-Bataille M; Burnichon N; Venisse A; Manivet P; Guignat L; Drui D; Chupin M; Josseaume C; Affres H; Plouin PF; Bertherat J; Jeunemaître X; Gimenez-Roqueplo AP
    J Clin Endocrinol Metab; 2012 May; 97(5):E805-9. PubMed ID: 22419703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole exome sequencing is an efficient and sensitive method for detection of germline mutations in patients with phaeochromcytomas and paragangliomas.
    McInerney-Leo AM; Marshall MS; Gardiner B; Benn DE; McFarlane J; Robinson BG; Brown MA; Leo PJ; Clifton-Bligh RJ; Duncan EL
    Clin Endocrinol (Oxf); 2014 Jan; 80(1):25-33. PubMed ID: 24102379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127).
    Gupta S; Zhang J; Milosevic D; Mills JR; Grebe SK; Smith SC; Erickson LA
    Endocr Pathol; 2017 Sep; 28(3):253-268. PubMed ID: 28646318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic status determines
    Tiwari A; Shah N; Sarathi V; Malhotra G; Bakshi G; Prakash G; Khadilkar K; Pandit R; Lila A; Bandgar T
    J Med Imaging Radiat Oncol; 2017 Dec; 61(6):745-752. PubMed ID: 28585398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Universal genetic screening uncovers a novel presentation of an SDHAF2 mutation.
    Casey R; Garrahy A; Tuthill A; O'Halloran D; Joyce C; Casey MB; O'Shea P; Bell M
    J Clin Endocrinol Metab; 2014 Jul; 99(7):E1392-6. PubMed ID: 24712571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
    Neumann HP; Pawlu C; Peczkowska M; Bausch B; McWhinney SR; Muresan M; Buchta M; Franke G; Klisch J; Bley TA; Hoegerle S; Boedeker CC; Opocher G; Schipper J; Januszewicz A; Eng C;
    JAMA; 2004 Aug; 292(8):943-51. PubMed ID: 15328326
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.